ログイン
Language:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 医学部
  1. 医学部
  2. 学術雑誌掲載論文  (医学部)

Efficacy of favipiravir treatment for patients with severe fever with thrombocytopenia syndrome assessed with a historical control

http://hdl.handle.net/10458/0002001885
http://hdl.handle.net/10458/0002001885
fc426501-d26c-4289-8460-8ad29ebb0c35
名前 / ファイル ライセンス アクション
saijo-et-al-2025-efficacy-of-favipiravir-treatment-for-patients-with-severe-fever-with-thrombocytopenia-syndrome.pdf fulltext (1.4 MB)
license.icon
アイテムタイプ 学術雑誌論文 / Journal Article(1)
公開日 2025-10-28
タイトル
タイトル Efficacy of favipiravir treatment for patients with severe fever with thrombocytopenia syndrome assessed with a historical control
言語 en
言語
言語 eng
キーワード
言語 en
キーワード Bandavirus dabieense
キーワード
言語 en
キーワード SFTS
キーワード
言語 en
キーワード SFTS virus
キーワード
言語 en
キーワード favipiravir
キーワード
言語 en
キーワード severe fever with thrombocytopenia syndrome
キーワード
言語 en
キーワード tick-borne virus infection
資源タイプ
資源タイプ journal article
アクセス権
アクセス権 open access
著者 Saijo, Masayuki

× Saijo, Masayuki

en Saijo, Masayuki(Personal)
National Institute of Infectious Diseases

Search repository
Izumikawa, Koichi

× Izumikawa, Koichi

en Izumikawa, Koichi(Personal)
Nagasaki University

Search repository
Suemori, Koichiro

× Suemori, Koichiro

en Suemori, Koichiro(Personal)
Ehime University

Search repository
Takahashi, Toru

× Takahashi, Toru

en Takahashi, Toru(Personal)
Yamaguchi Prefectural Grand Medical Center

Search repository
梅北, 邦彦

× 梅北, 邦彦

WEKO 21827
e-Rad_Researcher 20506084

ja 梅北, 邦彦
宮崎大学

ja-Kana ウメキタ, クニヒコ

en Umekita, Kunihiko
University of Miyazaki

Search repository
Ohge, Hiroki

× Ohge, Hiroki

en Ohge, Hiroki(Personal)
Hiroshima University

Search repository
Hatakenaka, Mariko

× Hatakenaka, Mariko

en Hatakenaka, Mariko(Personal)
Kochi Health Sciences Center

Search repository
Ikeda, Kenichi

× Ikeda, Kenichi

en Ikeda, Kenichi(Personal)
Kagoshima City Hospital

Search repository
Himeji, Daisuke

× Himeji, Daisuke

en Himeji, Daisuke(Personal)
Miyazaki Prefectural Miyazaki Hospital

Search repository
Yamanaka, Atushi

× Yamanaka, Atushi

en Yamanaka, Atushi(Personal)
Miyazaki Prefectural Miyazaki Hospital

Search repository
Kadowaki, Norimitsu

× Kadowaki, Norimitsu

en Kadowaki, Norimitsu(Personal)
Kagawa University

Search repository
Kawamura, Masafumi

× Kawamura, Masafumi

en Kawamura, Masafumi(Personal)
Kochi Prefectural Hata Kenmin Hospital

Search repository
Kakihana, Yasuyuki

× Kakihana, Yasuyuki

en Kakihana, Yasuyuki(Personal)
Kagoshima University

Search repository
Ito, Takuo

× Ito, Takuo

en Ito, Takuo(Personal)
NHO Kure Medical Center and Chugoku Cancer Center

Search repository
Nosaka, Kisato

× Nosaka, Kisato

en Nosaka, Kisato(Personal)
Kumamoto University

Search repository
Sakurai, Tsutomu

× Sakurai, Tsutomu

en Sakurai, Tsutomu(Personal)
FUJIFILM Toyama Chemical Co., Ltd

Search repository
Yoshikawa, Tomoki

× Yoshikawa, Tomoki

en Yoshikawa, Tomoki(Personal)
National Institute of Infectious Diseases

Search repository
Kurosu, Takeshi

× Kurosu, Takeshi

en Kurosu, Takeshi(Personal)
National Institute of Infectious Diseases

Search repository
Shimojima, Masayuki

× Shimojima, Masayuki

en Shimojima, Masayuki(Personal)
National Institute of Infectious Diseases

Search repository
Yasukawa, Masaki

× Yasukawa, Masaki

en Yasukawa, Masaki(Personal)
Ehime University

Search repository
抄録
内容記述タイプ Abstract
内容記述 Severe fever with thrombocytopenia syndrome (SFTS) is a disease caused by SFTS virus (SFTSV), an RNA virus, and endemic to Asia. The case fatality rate in Japan is estimated to be approximately 27%. Currently, no efficacious drugs are available. Favipiravir (FPV) has the potential to treat SFTS. However, no quantitative studies comparing FPV with conventional treatments have been conducted in the country. We conducted an open-label, interventional study in which patients with SFTS were administered FPV 1800 mg twice on the first day, followed by 800 mg twice daily for nine days. Additionally, we performed a retrospective observational study on patients with SFTS who received the best supportive care (BSC) without FPV treatment by collecting medical data from individuals at the same institutions. Patients aged 20-85 years were recruited, and blood samples were collected on Days 0 (pre-dose), 1, 3, 6, 9, 14, and 27 in the interventional study. Outcomes and laboratory parameters were compared by 1:1 matching using propensity score (PS). Thirty and 78 patients were enrolled in the FPV and the BSC groups, respectively. Twenty-three pairs were identified by PS matching. The risk ratio of fatality for the FPV group compared to the BSC group reduced to 0.500 after matching. Ferritin levels associated with hemophagocytosis severity were significantly different between the FPV and BSC groups on Days 3 to 9 after matching. No concerning serious adverse events were observed in the FPV group.This interventional study has been registered with the Japan Registry of Clinical Trials as jRCT2080223816.
言語 en
書誌情報 en : Antimicrobial agents and chemotherapy

p. e0106225, 発行日 2025-10-17
出版者
出版者 American Society for Microbiology
言語 en
ISSN
収録物識別子タイプ EISSN
収録物識別子 10986596
DOI
関連タイプ isVersionOf
識別子タイプ DOI
関連識別子 https://doi.org/10.1128/aac.01062-25
著者版フラグ
出版タイプ VoR
戻る
0
views
See details
Views

Versions

Ver.1 2025-10-28 02:34:41.048208
Show All versions

Share

Share
tweet

Cite as

Other

print

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX
  • ZIP

コミュニティ

確認

確認

確認


Powered by WEKO3


Powered by WEKO3